# US 2024/0226188 A9 · Compositions comprising animal hemoglobin

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0226188 A9
- Document ID: US20240226188A9
- Status: Published application
- Kind: A9
- Application number: 18/269,199
- Filed: 2021-12-21
- Published: 2024-07-11
- Earliest claimed: 2020-12-22
- Assignees: Evelo Biosciences, Inc.
- Applicants: Evelo Biosciences, Inc.
- Inventors: Alexander Bank
- Web page: https://patentgrep.com/patent/US20240226188A9

## CPC

- A61K 35/74: Bacteria (therapeutic use of a bacterial protein A61K38/00)
- A61K 9/2846: {Poly(meth)acrylates}
- A61K 9/4858: {Organic compounds}
- A61K 9/4891: {Coated capsules; Multilayered drug free capsule shells (with drug coating for immediate release A61K9/4808; osmotic devices A61K9/0004)}
- A61K 38/42: Haemoglobins; Myoglobins
- C07K 14/805: Haemoglobins; Myoglobins
- C12N 1/20: Bacteria; Culture media therefor
- C12N 1/205: Bacterial isolates
- G01N 33/721: {Haemoglobin}
- C12R 2001/01: Bacteria or Actinomycetales {; using bacteria or Actinomycetales}
- G01N 2333/36: from Actinomyces; from Streptomyces (G)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- C12R: INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS

## Abstract

Methods and compositions related to pharmaceutical agents, pharmaceutical compositions, and solid dosage forms comprising animal hemoglobin and bacteria or agents of bacterial origin are provided herein.

## Claims

### Claim 1

A bacterial composition comprising:
(a) bacteria and/or microbial extracellular vesicles (mEVs); and
(b) animal hemoglobin.

### Claim 2 (depends on 1)

The bacterial composition of claim 1, wherein the animal hemoglobin is porcine hemoglobin.

### Claim 3 (depends on 1, 2)

The bacterial composition of claim 1 or 2, wherein the bacterial composition comprises bacteria.

### Claim 4 (depends on 3)

The bacterial composition of claim 3, wherein the bacteria are hemoglobin-dependent bacteria.

### Claim 5 (depends on 3, 4)

The bacterial composition of claim 3 or 4, wherein the bacteria are of the genus Actinomyces, Alistipes, Anaerobutyricum, Bacillus, Bacteroides, Cloacibacillus, Clostridium, Collinsella, Cutibacterium, Eisenbergiella, Erysipelotrichaceae, Eubacterium/Mogibacterium, Faecalibacterium, Fournierella, Fusobacterium, Megasphaera, Parabacteroides, Peptoniphilus, Peptostreptococcus, Porphyromonas, Prevotella, Propionibacterium, Rarimicrobium, Shuttleworthia, Turicibacter, or Veillonella.

### Claim 6 (depends on 5)

The bacterial composition of claim 5, wherein the bacteria are of the genus Prevotella.

### Claim 7 (depends on 6)

The bacterial composition of claim 6, wherein the bacteria are Prevotella albensis, Prevotella amnii, Prevotella bergensis, Prevotella bivia, Prevotella brevis, Prevotella bryantii, Prevotella buccae, Prevotella buccalis, Prevotella copri, Prevotella dentalis, Prevotella denticola, Prevotella disiens, Prevotella histicola, Prevotella intermedia, Prevotella maculosa, Prevotella marshii, Prevotella melaninogenica, Prevotella micans, Prevotella multiformis, Prevotella nigrescens, Prevotella oralis, Prevotella oris, Prevotella oulorum, Prevotella pallens, Prevotella salivae, Prevotella stercorea, Prevotella tannerae, Prevotella timonensis, Prevotella jejuni, Prevotella aurantiaca, Prevotella baroniae, Prevotella colorans, Prevotella corporis, Prevotella dentasini, Prevotella enoeca, Prevotella falsenii, Prevotella fusca, Prevotella heparinolytica, Prevotella loescheii, Prevotella multisaccharivorax, Prevotella nanceiensis, Prevotella oryzae, Prevotella paludivivens, Prevotella pleuritidis, Prevotella ruminicola, Prevotella saccharolytica, Prevotella scopos, Prevotella shahii, Prevotella zoogleoformans, or Prevotella veroralis.

### Claim 8 (depends on 6)

The bacterial composition of claim 6, wherein the bacteria are of the species Prevotella histicola.

### Claim 9 (depends on 6)

The bacterial composition of claim 6, wherein the Prevotella comprise at least 99% genomic, 16S and/or CRISPR sequence identity to the nucleotide sequence of the Prevotella Strain B 50329 (NRRL accession number B 50329).

### Claim 10 (depends on 6)

The bacterial composition of claim 6, wherein the Prevotella comprise at least 99% genomic, 16S and/or CRISPR sequence identity to the nucleotide sequence of the Prevotella Strain C (ATTC Deposit Number PTA-126140).

### Claim 11 (depends on 6)

The bacterial composition of claim 6, wherein the Prevotella are Prevotella Strain B 50329 (NRRL accession number B 50329).

### Claim 12 (depends on 6)

The bacterial composition of claim 6, wherein the Prevotella are Prevotella Strain C (ATTC Deposit Number PTA-126140).

### Claim 13 (depends on 6)

The bacterial composition of claim 6, wherein the Prevotella bacteria (i) comprise one or more proteins listed in Table 3, and/or (ii) are substantially free of a protein listed in Table 4.

### Claim 14 (depends on 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13)

The bacterial composition of any one of claims 3 to 13, wherein the bacterial are live, attenuated, or dead.

### Claim 15 (depends on 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14)

The bacterial composition of any one of claims 3 to 14, wherein the bacteria are lyophilized bacteria.

### Claim 16 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15)

The bacterial composition of any one of claims 1-15, wherein the bacterial composition comprises mEVs.

### Claim 17 (depends on 16)

The bacterial composition of claim 16, wherein the mEVs are secreted mEVs (smEVs).

### Claim 18 (depends on 16)

The bacterial composition of claim 16, wherein the mEVs are processed mEVs (pmEVs).

### Claim 19 (depends on 16, 17, 18)

The bacterial composition of any one of claims 16 to 18, wherein the mEVs are from hemoglobin-dependent bacteria.

### Claim 20 (depends on 16, 17, 18, 19)

The bacterial composition of any one of claims 16 to 19, wherein the mEVs are from bacteria of the genus Actinomyces, Alistipes, Anaerobutyricum, Bacillus, Bacteroides, Cloacibacillus, Clostridium, Collinsella, Cutibacterium, Eisenbergiella, Erysipelotrichaceae, Eubacterium/Mogibacterium, Faecalibacterium, Fournierella, Fusobacterium, Megasphaera, Parabacteroides, Peptoniphilus, Peptostreptococcus, Porphyromonas, Prevotella, Propionibacterium, Rarimicrobium, Shuttleworthia, Turicibacter, or Veillonella.

### Claim 21 (depends on 20)

The bacterial composition of claim 20, wherein the mEVs are from bacteria of the genus Prevotella.

### Claim 22 (depends on 21)

The bacterial composition of claim 21, wherein the bacteria are Prevotella albensis, Prevotella amnii, Prevotella bergensis, Prevotella bivia, Prevotella brevis, Prevotella bryantii, Prevotella buccae, Prevotella buccalis, Prevotella copri, Prevotella dentalis, Prevotella denticola, Prevotella disiens, Prevotella histicola, Prevotella intermedia, Prevotella maculosa, Prevotella marshii, Prevotella melaninogenica, Prevotella micans, Prevotella multiformis, Prevotella nigrescens, Prevotella oxalis, Prevotella oris, Prevotella oulorum, Prevotella pallens, Prevotella salivae, Prevotella stercorea, Prevotella tannerae, Prevotella timonensis, Prevotella jejuni, Prevotella aurantiaca, Prevotella baroniae, Prevotella colorans, Prevotella corporis, Prevotella dentasini, Prevotella enoeca, Prevotella falsenii, Prevotella fusca, Prevotella heparinolytica, Prevotella loescheii, Prevotella multisaccharivorax, Prevotella nanceiensis, Prevotella oryzae, Prevotella paludivivens, Prevotella pleuritidis, Prevotella ruminicola, Prevotella saccharolytica, Prevotella scopos, Prevotella shahii, Prevotella zoogleoformans, or Prevotella veroralis.

### Claim 23 (depends on 21, 22)

The bacterial composition of claim 21 or 22, wherein the mEVs are from bacteria of the species Prevotella histicola.

### Claim 24 (depends on 21)

The bacterial composition of claim 21, wherein the Prevotella comprise at least 99% genomic, 16S and/or CRISPR sequence identity to the nucleotide sequence of the Prevotella Strain B 50329 (NRRL accession number B 50329).

### Claim 25 (depends on 21)

The bacterial composition of claim 21, wherein the Prevotella comprise at least 99% genomic, 16S and/or CRISPR sequence identity to the nucleotide sequence of the Prevotella Strain C (ATTC Deposit Number PTA-126140).

### Claim 26 (depends on 21)

The bacterial composition of claim 21, wherein the Prevotella are Prevotella Strain B 50329 (NRRL accession number B 50329).

### Claim 27 (depends on 21)

The bacterial composition of claim 21, wherein the Prevotella are Prevotella Strain C (ATTC Deposit Number PTA-126140).

### Claim 28 (depends on 21)

The bacterial composition of claim 21, wherein the Prevotella bacteria (i) comprise one or more proteins listed in Table 3, and/or (ii) are substantially free of a protein listed in Table 4.

### Claim 29 (depends on 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39)

The bacterial composition of any one of claims 16 to 39, wherein the mEVs are lyophilized mEVs.

### Claim 30 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29)

The bacterial composition of any one of claims 1 to 29, further comprising a cryoprotectant.

### Claim 31

A solid dosage form comprising:
(i) a pharmaceutical agent, wherein the pharmaceutical agent comprises
(a) bacteria and/or microbial extracellular vesicles (mEVs); and
(b) animal hemoglobin; and
(ii) at least one diluent, at least one lubricant, at least one glidant, and/or at least one disintegration agent.

### Claim 32

A solid dosage form comprising:
(i) a pharmaceutical agent, wherein the pharmaceutical agent comprises
(a) bacteria and/or microbial extracellular vesicles (mEVs); and
(b) animal hemoglobin; and
(ii) at least one diluent, at least one lubricant, and/or at least one glidant.

### Claim 33 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30)

A method of preventing or treating a disease in a subject comprising administering to the subject a pharmaceutical composition of any one of claims 1 to 30.

### Claim 34 (depends on 31)

A method of preventing or treating a disease in a subject comprising administering to the subject a solid dosage form of claim 31.

### Claim 35 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30)

Use of a pharmaceutical composition of any one of claims 1 to 30 for the treatment or prevention of a disease in a subject.

### Claim 36 (depends on 31)

Use of a solid dosage form of claim 31 for the treatment or prevention of a disease in a subject.

### Claim 37

A method of preparing a solid dosage form, the method comprising:
(A) combining into a pharmaceutical composition:
(i) a pharmaceutical agent, wherein the pharmaceutical agent comprises
(a) bacteria and/or microbial extracellular vesicles (mEVs); and
(b) animal hemoglobin; and
(ii) at least one diluent, at least one lubricant, at least one glidant, and/or at least one disintegration agent.
(B) compressing the pharmaceutical composition into a solid dosage form.

### Claim 38

A method of preparing a solid dosage form, the method comprising combining into a pharmaceutical composition:
(i) a pharmaceutical agent, wherein the pharmaceutical agent comprises
(a) bacteria and/or microbial extracellular vesicles (mEVs); and
(b) animal hemoglobin; and
(ii) at least one diluent, at least one lubricant, and/or at least one glidant.

### Claim 39

A method of testing a pharmaceutical composition comprising bacteria and/or microbial extracellular vesicles (mEVs), the method comprising performing an assay to detect the presence of an animal hemoglobin in the pharmaceutical composition.

### Claim 40 (depends on 39)

The method of claim 39, wherein the animal hemoglobin is porcine hemoglobin.

### Claim 41 (depends on 39, 40)

The method of claim 39 or 40, wherein the animal hemoglobin protein is detected using an antibody specific for the animal hemoglobin protein, HPLC or UPLC.

### Claim 42 (depends on 39, 40, 41)

The method of any one of claims 39 to 41, wherein the pharmaceutical composition comprises bacteria.

### Claim 43 (depends on 42)

The method of claim 42, wherein the bacteria are hemoglobin-dependent bacteria.

### Claim 44 (depends on 42, 43)

The method of claim 42 or 43, wherein the bacteria are of the genus Actinomyces, Alistipes, Anaerobutyricum, Bacillus, Bacteroides, Cloacibacillus, Clostridium, Collinsella, Cutibacterium, Eisenbergiella, Erysipelotrichaceae, Eubacterium/Mogibacterium, Faecalibacterium, Fournierella, Fusobacterium, Megasphaera, Parabacteroides, Peptoniphilus, Peptostreptococcus, Porphyromonas, Prevotella, Propionibacterium, Rarimicrobium, Shuttleworthia, Turicibacter, or Veillonella.

### Claim 45 (depends on 44)

The method of claim 44, wherein the bacteria are of the genus Prevotella.

### Claim 46 (depends on 45)

The method of claim 45, wherein the bacteria are Prevotella albensis, Prevotella amnii, Prevotella bergensis, Prevotella bivia, Prevotella brevis, Prevotella bryantii, Prevotella buccae, Prevotella buccalis, Prevotella copri, Prevotella dentalis, Prevotella denticola, Prevotella disiens, Prevotella histicola, Prevotella intermedia, Prevotella maculosa, Prevotella marshii, Prevotella melaninogenica, Prevotella micans, Prevotella multiformis, Prevotella nigrescens, Prevotella oxalis, Prevotella oris, Prevotella oulorum, Prevotella pallens, Prevotella salivae, Prevotella stercorea, Prevotella tannerae, Prevotella timonensis, Prevotella jejuni, Prevotella aurantiaca, Prevotella baroniae, Prevotella colorans, Prevotella corporis, Prevotella dentasini, Prevotella enoeca, Prevotella falsenii, Prevotella fusca, Prevotella heparinolytica, Prevotella loescheii, Prevotella multisaccharivorax, Prevotella nanceiensis, Prevotella oryzae, Prevotella paludivivens, Prevotella pleuritidis, Prevotella ruminicola, Prevotella saccharolytica, Prevotella scopos, Prevotella shahii, Prevotella zoogleoformans, or Prevotella veroralis.

### Claim 47 (depends on 45, 46)

The method of claim 45 or 46, wherein the bacteria are of the species Prevotella histicola.

### Claim 48 (depends on 45)

The method of claim 45, wherein the Prevotella bacteria comprise at least 99% genomic, 16S and/or CRISPR sequence identity to the nucleotide sequence of the Prevotella Strain B 50329 (NRRL accession number B 50329).

### Claim 49 (depends on 45)

The method of claim 45, wherein the Prevotella comprise at least 99% genomic, 16S and/or CRISPR sequence identity to the nucleotide sequence of the Prevotella Strain C (ATTC Deposit Number PTA-126140).

### Claim 50 (depends on 45)

The method of claim 45, wherein the Prevotella are Prevotella Strain B 50329 (NRRL accession number B 50329).

### Claim 51 (depends on 45)

The method of claim 45, wherein the Prevotella are Prevotella Strain C (ATTC Deposit Number PTA-126140).

### Claim 52 (depends on 45)

The method of claim 45, wherein the Prevotella bacteria (i) comprise one or more proteins listed in Table 3, and/or (ii) are substantially free of a protein listed in Table 4.

### Claim 53 (depends on 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52)

The method of any one of claims 39 to 52, wherein the bacteria are live, attenuated, or dead.

### Claim 54 (depends on 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53)

The method of any one of claims 39 to 53, wherein the bacteria are lyophilized bacteria.

### Claim 55 (depends on 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54)

The method of any one of claims 39 to 54, wherein the pharmaceutical composition comprises mEVs.

### Claim 56 (depends on 55)

The method of claim 55, wherein the mEVs are secreted mEVs (smEVs).

### Claim 57 (depends on 55)

The method of claim 55, wherein the mEVs are processed mEVs (pmEVs).

### Claim 58 (depends on 55, 56, 57)

The method of any one of claims 55 to 57, wherein the mEVs are from hemoglobin-dependent bacteria.

### Claim 59 (depends on 55, 56, 57, 58)

The method of any one of claims 55 to 58, wherein the mEVs are from bacteria of the genus Actinomyces, Alistipes, Anaerobutyricum, Bacillus, Bacteroides, Cloacibacillus, Clostridium, Collinsella, Cutibacterium, Eisenbergiella, Erysipelotrichaceae, Eubacterium/Mogibacterium, Faecalibacterium, Fournierella, Fusobacterium, Megasphaera, Parabacteroides, Peptoniphilus, Peptostreptococcus, Porphyromonas, Prevotella, Propionibacterium, Rarimicrobium, Shuttleworthia, Turicibacter, or Veillonella.

### Claim 60 (depends on 59)

The method of claim 59, wherein the mEVs are from bacteria of the genus Prevotella.

### Claim 61 (depends on 60)

The method of claim 60, wherein the bacteria are Prevotella albensis, Prevotella amnii, Prevotella bergensis, Prevotella bivia, Prevotella brevis, Prevotella bryantii, Prevotella buccae, Prevotella buccalis, Prevotella copri, Prevotella dentalis, Prevotella denticola, Prevotella disiens, Prevotella histicola, Prevotella intermedia, Prevotella maculosa, Prevotella marshii, Prevotella melaninogenica, Prevotella micans, Prevotella multiformis, Prevotella nigrescens, Prevotella ovalis, Prevotella oris, Prevotella oulorum, Prevotella pallens, Prevotella salivae, Prevotella stercorea, Prevotella tannerae, Prevotella timonensis, Prevotella jejuni, Prevotella aurantiaca, Prevotella baroniae, Prevotella colorans, Prevotella corporis, Prevotella dentasini, Prevotella enoeca, Prevotella falsenii, Prevotella fusca, Prevotella heparinolytica, Prevotella loescheii, Prevotella multisaccharivorax, Prevotella nanceiensis, Prevotella oryzae, Prevotella paludivivens, Prevotella pleuritidis, Prevotella ruminicola, Prevotella saccharolytica, Prevotella scopos, Prevotella shahii, Prevotella zoogleoformans, or Prevotella veroralis.

### Claim 62 (depends on 60, 61)

The method of claim 60 or 61, wherein the mEVs are from bacteria of the species Prevotella histicola.

### Claim 63 (depends on 60)

The method of claim 60, wherein the Prevotella comprise at least 99% genomic, 16S and/or CRISPR sequence identity to the nucleotide sequence of the Prevotella Strain B 50329 (NRRL accession number B 50329).

### Claim 64 (depends on 60)

The method of claim 60, wherein the Prevotella comprise at least 99% genomic, 16S and/or CRISPR sequence identity to the nucleotide sequence of the Prevotella Strain C (ATTC Deposit Number PTA-126140).

### Claim 65 (depends on 60)

The method of claim 60, wherein the Prevotella are Prevotella Strain B 50329 (NRRL accession number B 50329).

### Claim 66 (depends on 60)

The method of claim 60, wherein the Prevotella are Prevotella Strain C (ATTC Deposit Number PTA-126140).

### Claim 67 (depends on 60)

The method of claim 60, wherein the Prevotella bacteria (i) comprise one or more proteins listed in Table 3, and/or (ii) are substantially free of a protein listed in Table 4.
